provide comprehensive care at CHAM Kerry Morrone, MD Director of - - PowerPoint PPT Presentation

provide comprehensive care at
SMART_READER_LITE
LIVE PREVIEW

provide comprehensive care at CHAM Kerry Morrone, MD Director of - - PowerPoint PPT Presentation

Sickle Cell Anemia -striving to provide comprehensive care at CHAM Kerry Morrone, MD Director of the Pediatric Sickle Cell Program 11-2-16 montekids.org Objectives Demonstrate how to interpret a hemoglobin electrophoresis Update on


slide-1
SLIDE 1

montekids.org

Sickle Cell Anemia -striving to provide comprehensive care at CHAM

Kerry Morrone, MD Director of the Pediatric Sickle Cell Program 11-2-16

slide-2
SLIDE 2

montekids.org

Objectives

  • Demonstrate how to interpret a hemoglobin

electrophoresis

  • Update on treatment guidelines from the NHLBI
  • Review vaccination guidelines
  • Overview on special considerations in prescribing

medications or performing surgical procedures in sickle cell disease

slide-3
SLIDE 3

montekids.org

Prevalence in U.S 90-100,000 Incidence in Africa 200,000 infants/year

Sickle Cell Disease: A Public Health Problem

slide-4
SLIDE 4

montekids.org

Hemoglobin Structure

slide-5
SLIDE 5

montekids.org

Stuart . 2014 Lancet

Pathophysiology of vaso-occulsion

slide-6
SLIDE 6

montekids.org

Name Genotype Percent

Homozygous SS

(Sickle Cell Anemia)

S-S 65 Heterozygous SC

(Hb SC Disease)

S- C 24 Heterozygous S-+ thal S- + thal 7 Heterozygous S-° thal S- ° thal 3

slide-7
SLIDE 7

montekids.org

Mortality in sickle cell disease-more to be done

slide-8
SLIDE 8

montekids.org

Perspectives from a clinical case

  • Two siblings present with their parents to clinic

after recently immigrating from Liberia.

  • They think their children may have a blood

disorder, but are unsure.

  • Fareed the 10 year old child had to be

hospitalized several times for infection and gets pain intermittently

  • Kadida is 2 years old and has not had any

complications

slide-9
SLIDE 9

montekids.org

How would you test this family? What are the methods to screen for sickle cell trait/disease?

  • As of 2006 all 50 states now require new born screen

testing for sickle cell disease

  • Best screening methods: hemoglobin electrophoresis,

HPLC, isoelectric focusing

  • Sickle cell solubility test has many potential errors
  • NCAA offers testing of all athletes in Divisions I-III
  • 16 % of individuals and 37 % of parents of children

tested are aware of their sickle cell carrier status

Treadwell et al. J Nat Med Assoc . 2006 Naik and Haywood. 2015. Ash Education Program

slide-10
SLIDE 10

montekids.org

Perspectives from a clinical case

  • Fareed’s labs:
  • 15>7/24<550
  • MCV: 75
  • Retic: 10
  • LDH: 400
  • TB/DB: 2.5/.4
  • Hemoglobin electrophoresis:
  • S%: 90 A2%: 3 F%: 7
  • Kadida’s labs:
  • 5>12/36<300
  • MCV: 75
  • Retic: 1
  • LDH: 200
  • TB/DB: .4/.2
  • Hemoglobin electrophoresis:
  • S%: 25 A%: 65 A2%: 3 F%: 7

What do you inform this family?

slide-11
SLIDE 11

montekids.org

Perspectives from a clinical case

  • The family is informed that Fareed has SS

disease and that Kadida has sickle trait .

  • The family wants to discuss the risk factors for

Kadida and want to know what does the literature say?

slide-12
SLIDE 12

montekids.org

Are there additional risks of having sickle cell trait ?

  • No systematic review of complications
  • Exertional related injury documented in

retrospective reports

  • NEJM- 2016 not increased
  • Chronic kidney disease and albuminuira – 1.57

OR (CI 1.34-1.84)

Naik et al. 2014 JAMA Kark JA et al. 1987 NEJM Harmon KG et al. 2012 Br J Sports

slide-13
SLIDE 13

montekids.org

Another common scenario…

  • Destiny is a 2 month old born in Florida whose

family has moved to the Bronx this week and mom wants to establish care

  • Mom knows there is sikcle cell trait in her family

and missed her follow up appointment to go

  • ver newborn screen results. She asks for her

daughter to be tested

slide-14
SLIDE 14

montekids.org

Another common scenario…

  • 10>12<350 MCV: 75 retic: 1.5
  • Hemoglobin electrophoresis: S-20 % F->40%

A2:5%

  • Does this patient have sickle cell disease or

trait?

  • Do they need any additional follow up or

treatments ?

slide-15
SLIDE 15

montekids.org

Another common scenario…

  • This patient has sickle cell disease and should

be started on penicillin prophylaxis and referred to a hematologist

  • Fetal hemoglobin is elevated in the newborn

period

  • In sickle cell disease the level of fetal

hemoglobin is not stabilized even up until 5 years old

slide-16
SLIDE 16

montekids.org

30 years later from the landmark prophylaxis study …

slide-17
SLIDE 17

montekids.org

Vaccination recommendations

  • Steinberg. 2015 BJH
slide-18
SLIDE 18

montekids.org

What is the rate of infection post vaccination era?

  • Post vaccine rate of bacteremia: .8 % in setting
  • f febrile episodes
  • Presence of a central venous line, band count,

clinical appearance and age helped to predict bacteremia

  • Patients still require a blood culture, broad

spectrum antibiotics and ability to have close follow up

Chang et al. 2013

slide-19
SLIDE 19

montekids.org

What does the CDC suggest for meningococcal vaccinations?

  • New updates for children with anatomic or functional

asplenia (including sickle cell disease):

  • Can start vaccinating at 2 months old with Menveo or

Menhibirix

  • If start vaccinating at 2 months then should receive

vaccines at 2,4, 6 and 12 months

  • Catch up vaccine schedule
  • Menactra can be used in over 2 years of age
slide-20
SLIDE 20

montekids.org

At 430 pm on a Friday afternoon

  • Jose and his mother present to the Adolescent

doctor for his routine visit

  • He is noted to be tachypneic and febrile to 102
  • He states he was febrile this morning but felt

better after motrin.

  • Besides the tachypnea he is very well

appearing and states he wants to go home..

  • What do you do ?
slide-21
SLIDE 21

montekids.org

NHLBI guidlelines for fever

slide-22
SLIDE 22

montekids.org

  • Jose is seen in the emergency room and as the resident

is doing medication reconciliation they notice he is on hydroxyurea

  • On further questioning Jose states he has had very few

crises and very minimal complications

  • The family states his hematologist suggested he be on it

for his general health

  • Is there an indication to do that?

Hydroxyurea- who , when and why ?

slide-23
SLIDE 23

montekids.org

 Randomized phase III trial  9-18 months  N=193  18 month follow up  Excellent safety profile  Decreased pain crisis  Decreased dactylitis  Improved hemoglobin  Decreased inpatient

hospitalization costs

Wang Pediatrics 2013

slide-24
SLIDE 24

montekids.org

< 5 yrs 5 <10yrs 10 <15yrs >15yrs Never

Death Stroke Renal Disease Hepatic disease Sepsis/Infection

slide-25
SLIDE 25

montekids.org

NHLBI 2014 Guidelines: Hydroxyurea

****

slide-26
SLIDE 26

montekids.org

  • Jose tells you he is also upset because he is supposed to

have surgery tomorrow to help with his snoring

  • He is afraid his fever will prevent him from getting the

surgery

  • After checking his labs his hemoglobin returns at 8 , retic:

10

  • If he is feeling better should be just go to the ambulatory

suite tomorrow to remove his tonsils?

Surgical considerations

slide-27
SLIDE 27

montekids.org

What are common surgeries or procedures for patients with sickle cell anemia?

  • Tonsillectomy & adenoidectomy
  • Cholecystectomy
  • Orthopedic procedures (core decompression of

hip)

  • Splenectomy
slide-28
SLIDE 28

montekids.org

Procedural/Surgical Preparations for Sickle Cell Disease

slide-29
SLIDE 29

montekids.org

Procedure/Surgical Preparation

  • Refer to your patient’s hematologist
  • Blood work is done and patients are optimized

by blood transfusions and/or IVF

  • Patients typically admitted the night prior to

surgery or procedure if it requires sedation

  • Medical clearance should be provided by

hematologist

slide-30
SLIDE 30

montekids.org

By request: special considerations

  • No estrogen containing contraception
  • Steriods- to be used judiciously and tapered for

risk of VOC and ACS rebound

  • Headache restrictions (triptans)

Whitley- ASH education book

slide-31
SLIDE 31

montekids.org

Objectives

  • Demonstrate how to interpret a hemoglobin

electrophoresis

  • Update on treatment guidelines from the NHLBI
  • Review vaccination guidelines
  • Overview on special considerations in prescribing

medications or performing surgical procedures in sickle cell disease

slide-32
SLIDE 32

montekids.org

CHAM Pediatric Hematology team